Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Aquestive Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of AQST: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders982117+21
Shares42.5M5.46M46.8M+9.68M (+26.1%)
Value$110.7M$14.2M$232.4M+$136.0M (+141.0%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AQST in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.5,823,077$29.0M0.00%
MPM Oncology Impact Management LP1,796,750$8.95M1.34%
Everstar Asset Management, LLC400,125$1.99M1.37%
Verition Fund Management LLC199,729$994.6K0.01%
Wellington Management Group LLP185,191$922.3K0.00%
AQR Capital Management LLC130,800$651.4K0.00%
Chartwell Investment Partners, LLC107,550$535.0K0.02%
Russell Investments Group, Ltd.67,887$338.1K0.00%
Stratos Wealth Partners, LTD.50,000$249.0K0.00%
ExodusPoint Capital Management, LP47,523$237.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.40,753$202.9K0.00%
Deutsche Bank AG37,819$188.3K0.00%
Levin Capital Strategies, L.P.35,000$174.3K0.02%
Balyasny Asset Management LLC28,937$144.1K0.00%
Quantbot Technologies LP27,198$135.4K0.01%
Pale Fire Capital SE24,000$119.5K0.02%
Ancora Advisors, LLC21,246$105.8K0.00%
Bayesian Capital Management, LP19,700$98.1K0.01%
Intech Investment Management LLC18,032$89.8K0.00%
Harvey Capital Management Inc17,600$87.6K0.02%
HSBC Holdings PLC14,493$73.0K0.00%
Prudential Financial Inc14,475$72.1K0.00%
ProShare Advisors LLC14,032$69.9K0.00%
Simplex Trading, LLC12,540$62.0K0.00%
nVerses Capital, LLC5,700$28.4K0.01%
Group One Trading, L.P.5,395$26.9K0.00%
Torno Capital, LLC4,200$20.9K0.03%
US Bancorp2,250$11.2K0.00%
Avion Wealth1,000$4.00K0.00%
CWM, LLC515$3.00K0.00%
Nisa Investment Advisors, LLC205$1.02K0.00%
Sterling Capital Management LLC193$9610.00%
Capital Performance Advisors LLP119$5930.00%
Lindbrook Capital, LLC109$5430.00%
Northwestern Mutual Wealth Management Co50$2490.00%
True Wealth Design, LLC47$2350.00%
National Bank of Canada4$200.00%
International Assets Investment Management, LLC19,920––

Sold out (17)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AQST in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.5,454,743$14.2M
ICA Group Wealth Management, LLC2,590$6.73K